# OnCo record laguna-biotherapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/laguna-biotherapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "laguna-biotherapeutics" ;
  schema:name "Laguna Biotherapeutics"@en ;
  schema:alternateName "Laguna Bio"@en ;
  schema:description "Laguna Biotherapeutics uses weakened, engineered bacteria as medicines that switch on unusual immune cells able to attack cancer. Its first product, QUAIL-100, is starting a trial in children and young adults with high-risk leukaemia after a stem cell transplant."@en ;
  schema:url <https://onco.cc/companies/laguna-biotherapeutics/>, <https://lagunabio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://lagunabio.com/>, <https://lagunabio.com/news/pnas-publication-highlights-therapeutic-potential-of-engineered-listeria>, <https://clinicaltrials.gov/study/NCT07573111> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/engineered-bacteria-therapy/> .